Poor visual outcomes after big bubble deep anterior lamellar keratoplasty may be attributable to large vitreous length, higher-order aberrations and surgical interface haze, according to a study. “Our results reflect the fact that differences in postoperative visual acuity are independent of corneal features and show that the main factor that contributed to decreases in [best corrected visual acuity] was an elongated posterior segment,” the study authors said.
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY) a biopharmaceutical company focusing on commercializing its Avenova® Lid and Lash Cleanser for the domestic eye care market, announces that it has entered into three securities purchase agreements for the sale of 1,518,567 shares of common stock for approximately $2.83 million. Investors in the private placement include Mr. Jian Ping Fu and Pioneer Pharma (Singapore) Pte. Ltd. Mr. Fu is President of Greenwood Cap
(MedPage Today) — Congress won’t pass many bills in a presidential election year
The FDA announced that the U.S. Senate voted to confirm Robert Califf, MD, MACC, as commissioner of the agency.Califf, who was named deputy commissioner for medical products and tobacco in January 2015, was nominated by President Obama in September 201…
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/rnz2xt/cataractglobal) has announced the addition of the “Cataract-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016” report to their offerin…
Since the 2005 Liverpool Declaration, Europe has made significant progress toward implementation of systematic national screening programs to reduce diabetes-related visual impairment. However, barriers still remain in countries with predominantly private, insurance-based health care systems or countries that lack human and financial resources, Simon Harding, FRCS, FRCOphth, MD, chair professor of Clinical Ophthalmology at the University of Liverpool and St. Paul’s Eye Unit, Royal Liverpool University Hospital, United Kingdom, said.The Liverpool Declaration was the result of a consensus conference, gathering official national representatives of 29 European countries, invited experts and health professionals with expertise in the field of diabetes and diabetic retinopathy. It revised and updated the previous 1989 St. Vincent Declaration, setting the targets and strategies for reduction of diabetes-related visual impairment. Aims to achieve by 2010 included systematic screening programs reaching at least 80% of the population with diabetes, increased availability of trained specialists and universal access to therapy. Two meetings followed in 2008 and 2011 in Amsterdam and Gdansk to review progress and set new targets. The next meeting will be held on June 23 in Manchester.